🚨 THIS MAY BECOME ONE OF THE BIGGEST INSIDER TRADING SCANDALS IN CONGRESS HISTORY.



A US Congressman’s household disclosed nearly 38,000 stock trades while overseeing the exact industries being traded.

AI. Semiconductors. Defense. Healthcare. China policy.

Total disclosed trading volume: over $631 MILLION.

Now a massive 239-page ethics complaint is accusing Rep. Ro Khanna’s household of generating millions through suspiciously timed trades linked to congressional activity.

The complaint claims roughly $28 million in above-market profits came from trades made around major government events and policy decisions. It also accuses the household of 624 late STOCK Act filings, defense contractor trades during Pentagon oversight, AI chip trades during semiconductor policy debates, and healthcare trades near federal regulatory decisions.

And the overlap is extremely difficult to ignore.

Khanna sits on committees directly connected to defense spending, AI and semiconductors, export controls, healthcare oversight, and US-China technology policy. At the same time, his household was heavily trading companies exposed to those exact sectors.

Nvidia became one of the biggest examples. His household reportedly held Nvidia during the AI boom while Congress debated semiconductor policy, AI regulation and China chip restrictions.

Another analysis claimed his AI-related trades outperformed the S&P 500 by over 112%. Even Nancy Pelosi’s famous trading record was reportedly lower.

The New York Times previously identified 149 potential conflicts connected to Khanna’s trading activity.

And this is where the controversy becomes even more unbelievable:

Khanna publicly supports banning congressional stock trading. But his household became one of the most active trading operations in Congress.

In 2025 alone, over 4,000 trades were disclosed.

Khanna denies wrongdoing and says the trades are managed by an independent family trust created before he entered Congress. But critics argue the trust is NOT a true qualified blind trust under congressional ethics law.
$NVDAB
US500-1.26%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments